Last reviewed · How we verify

Fish oils — Competitive Intelligence Brief

Fish oils (Fish oils) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Omega-3 polyunsaturated fatty acid supplement. Area: Cardiovascular.

phase 3 Omega-3 polyunsaturated fatty acid supplement Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Fish oils (Fish oils) — The University of Western Australia. Fish oils provide omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce inflammation and modulate lipid metabolism.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fish oils TARGET Fish oils The University of Western Australia phase 3 Omega-3 polyunsaturated fatty acid supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Omega-3 polyunsaturated fatty acid supplement class)

  1. The University of Western Australia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fish oils — Competitive Intelligence Brief. https://druglandscape.com/ci/fish-oils. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: